Walmart and Target will report earnings next week, providing fresh insight into how Americans are faring shortly after retail ...

Should Kennedy win Senate confirmation, critics say a radical antiestablishment medical movement would take power.

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

With President-elect Donald Trump returning to the White House, a changing of the guard at the Federal Trade Commission (FTC) ...

Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent ...

The nonprofit partnered with MullenLowe to develop a campaign based on data from its biannual customer and patient experience ...

However, Paul Hudson, CEO of Sanofi, one of the world's leading biopharmaceutical companies, says executives may need to rein ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Source: Sanofi Besides health initiatives, Sanofi has executed campaigns that ... Self-care unlocks potential of fast-moving consumer healthcare in Vietnam The wave of self-care in Vietnam allows ...

Sanofi’s decision to cancel the spin-off ... Its healthcare solutions are available in more than 180 countries worldwide. Consumer Health Company (Opella) (Sold-Out entity) Headquartered in ...

The sale comes as Sanofi aims to accelerate its R&D investments and increase focus on its biopharma business. The move reflects a wider trend across the industry, with several major pharma companies ...